Evaluation of the acceptance and efficacy of a bespoke sun protection package for persons with oculocutaneous albinism living in Malawi.
Journal
International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
28
04
2021
received:
03
10
2020
accepted:
30
06
2021
pubmed:
8
9
2021
medline:
10
2
2022
entrez:
7
9
2021
Statut:
ppublish
Résumé
Skin cancer is the main cause of death in persons with albinism (PWA) in Africa. Education would minimize sun damage. To evaluate the efficacy and acceptance of a photoprotection educative and sunscreen (Umozi Max) package designed for PWA in reducing sunburns and skin cancer. A multicenter, noncontrolled, before-and-after, interventional study was conducted in PWA > 12 years of age, from February to May, 2019, in Malawi. During the baseline and the follow-up visits (at 8 and 15 weeks), subjects received an educational program designed to PWA and use of Umozi Max. At every visit, photoprotection behavior and knowledge were checked and cutaneous lesions were recorded. Univariate and bivariate analysis were performed. A total of 210 PWA were analyzed, 50% males, with a mean age of 24.5 (SD 11.29) years. The percentage of people using sun protective clothing increased from 80% to 100% and sunscreen from 81.9% to 99.5%. People avoiding the midday sun increased by 38.9% (P < 0.05). Participants that erroneously applied the sunscreen at night diminished from 40% to 4% (P < 0.001). Absent erythema on the face increased from 40% to 90% (P < 0.05). The percentage of patients with actinic keratoses (AK) on all locations significantly decreased during the study. All the participants preferred Umozi Max to previously used sunscreens. The satisfaction with the program was unanimous. The educational program enhanced the use of all photoprotection measures, improved behaviors, and decreased the incidence of solar erythema and contributed to decreasing the incidence of new AKs.
Substances chimiques
Sunscreening Agents
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
352-360Subventions
Organisme : Africa Directó
Informations de copyright
© 2021 the International Society of Dermatology.
Références
Hong ES, Hajo Z, Repachoil MH. Albinism in Africa as a public health issue. BMC Public Health 2006; 6:212.
Luande J, Henschke CI, Mohammed N. The Tanzanian human albino skin. Natural history Cancer 1985; 55: 1823-1828.
Saka B, Mouhari-Toure A, Adam S, et al. Dermatological and epidemiological profile of patients with albinism in Togo in 2019: results of two consultation campaigns. Int J Dermatol 2020; 59: 1076-1081.
Green AC, Williams CM. Point: sunscreen use is a safe and effective approach to skin cancer prevention. Cancer Epidemiol Biomarkers Prev 2007; 16: 1921-1922.
Randhawa M, Wang S, Leyden JJ, et al. Daily use of a facial broad spectrum sunscreen over one-year significantly improves clinical evaluation of photoaging. Dermatol Surg 2016; 42: 1354-1361.
Van der Pols JC, Williams GM, Pandeya N, et al. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15: 2546-2548.
Kiprono SK, Chaula BM, Beltraminelli H. Histological review of skin cancers in African albinos: a 10-year retrospective review. BMC Cancer 2014; 14: 157.
de Troya-Martín M, Blázquez-Sánchez N, Rivas-Ruiz F, et al. Validation of a Spanish questionnaire to evaluate habits, attitudes, and understanding of exposure to sunlight: "the beach questionnaire". Actas Dermosifiliogr 2009; 100: 586-595.
Randhawa M, Steven Wang MD, Leyden JJ. Daily use of a facial broad-spectrum sunscreen over one-year significantly improves clinical evaluation of photoaging. Am Soc Dermatol Surg Dermatol Surg 2016; 2016: 1354-1361.
Lookingbill DP, Lookingbill GL, Leppard B. Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in in an outreach skin care program. J Am Acad Dermatol 1995; 32: 653-658.
McBride SR, Leppard BJ. Attitudes and beliefs of an albino population toward sun avoidance. Advice and services provided by an outreach albino clinic in Tanzania. Arch Dermatol 2002; 138: 629-632.
McBride SR, Leppard BJ. Attitudes and beliefs of an albino population toward sun population toward sun avoidance: advices and services provided by an Outreach Albino clinic in Tanzania. Arch Dermatol 1998; 2002: https://doi.org/10.1001/archderm.138.5.629.
Marti A, Lasseaux E, Ezzedine K, et al. Lessons of a day hospital : comprehensive assessment of patients with albinism in European setting. Pigment Cell Melanoma Res 2018; 31: 318-329.
Diffey BL. Sunscreens and UVA protection: a major issue of minor importance. PhotochemPhotobiol 2001; 74: 61-63.
Zschocke I, Mrowietz U, Lotzin A, et al. Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ). Arch Dermatol Res 2014; 306: 287-297.
Martin LR, Williams SL, Haskard KB, DiMatteo MR. The challenge of patient adherence. Ther Clin Risk Manag 2005; 1: 189-199.
Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in anoutpatient clinic. J Am AcadDermatol 2008; 59: 27-33.
Osterwalder U, Herzog B. The long way towards the ideal sunscreen-where we stand and what still needs to be done. Photochem Photobiol Sci 2010; 9: 470-481.
Kattelmann B. (2015). A special beauty. www.cosmeticsbusinesscom April 2015 SPC 83-87.
Bryden Am, Moseley H, Ibbotson SH, et al. Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. British J Dermatol 2006; 155(4): 737-747.
Shaw T, Simpson B, Wilson B, et al. True photoallergy to sunscreens is rare despite popular belief. Dermatitis 2010; 21: 185-198.
Ruszkiewicz JA, Pinkas A, Ferrer B, et al. Neurotoxic effect of active ingredients in sunscreen products, a contemporary review. Elsevier Toxicol Rep 2017; 4: 245-259.
Schneider SL, Lim HW. Review of environmental effects of oxybenzone and other sunscreen active ingredients. J Am Acad Dermatol 2019; 2019: 266-271.
Krause M, Klit A, Blomberg Jensen M, Søeborg T. Sunscreens: are they beneficial for health? An overview of endocrine disrupting properties of UV-filters. Int J Androl 2012; 35: 424-436. [2] S.C. Thompson, D. Jolley, R. Mark.
RIFM Expert Panel, Belsito D, Bickers D. A toxicological and dermatological assessment of aryl alkyl alcohol simple acid ester derivatives when used as fragrance ingredients. US National Library of Medicine National Institutes of Health 2012; 50(Suppl 2): S269-313.
Nair B. Final report on the safety assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate. Int J Toxicol 2001; 20(Suppl 3): 23-50.
Cruz-Inigo AE, Ladizinski B, Sethi A. Albinism in Africa: Stigma, Slaughter and Awareness Campaigns. Elsevier Dermatol Clin 2011; 29: 79-87.
Montague M, Borland R, Sinclair C. Slip! Slop! And SunSmart, 1980-2000:skin cancer control and 20 years of population-based campaigning. Health Educ Behav 2001; 28: 290-305.
Moyer VA, U.S. Preventive Services Task Force. Behavioral counseling to prevent skin cancer: US preventive services task forces recommendation statement. Ann Intern Med 2012; 157.